Detalles de la búsqueda
1.
TP53 DNA binding domain mutational status and rituximab-based treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385281
2.
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP).
Ann Hematol
; 101(8): 1843-1851, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35726104
3.
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.
Pediatr Blood Cancer
; 69(10): e29801, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35656841
4.
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial.
Transplant Cell Ther
; 30(5): 530.e1-530.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38460729
5.
Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience.
Cancers (Basel)
; 14(6)2022 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326622
6.
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol.
Neuro Oncol
; 24(3): 467-479, 2022 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34605902
Resultados
1 -
6
de 6
1
Próxima >
>>